Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends.
Posa A, Contegiacomo A, Ponziani FR, Punzi E, Mazza G, Scrofani A, Pompili M, Goldberg SN, Natale L, Gasbarrini A, Sala E, Iezzi R. Posa A, et al. Among authors: mazza g. Int J Mol Sci. 2023 Apr 16;24(8):7344. doi: 10.3390/ijms24087344. Int J Mol Sci. 2023. PMID: 37108507 Free PMC article. Review.
Technological Advancements in Interventional Oncology.
Posa A, Barbieri P, Mazza G, Tanzilli A, Natale L, Sala E, Iezzi R. Posa A, et al. Among authors: mazza g. Diagnostics (Basel). 2023 Jan 7;13(2):228. doi: 10.3390/diagnostics13020228. Diagnostics (Basel). 2023. PMID: 36673038 Free PMC article. Review.
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS; COURSE study investigators. Singh D, et al. Lancet Respir Med. 2025 Jan;13(1):47-58. doi: 10.1016/S2213-2600(24)00324-2. Epub 2024 Dec 6. Lancet Respir Med. 2025. PMID: 39653044
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).
Lee MK, Mitchell SA, Basch E, Mazza GL, Langlais BT, Thanarajasingam G, Ginos BF, Rogak L, Meek EA, Jansen J, Deal AM, Carr P, Blinder VS, Jonsson M, Mody GN, Mendoza TR, Bennett AV, Schrag D, Dueck AC. Lee MK, et al. Among authors: mazza gl. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03819-5. Online ahead of print. Qual Life Res. 2024. PMID: 39503942
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample.
Mead-Harvey C, Basch E, Rogak LJ, Langlais BT, Thanarajasingam G, Ginos BF, Lee MK, Yee C, Mitchell SA, Minasian LM, Mendoza TR, Bennett AV, Schrag D, Dueck AC, Mazza GL. Mead-Harvey C, et al. Among authors: mazza gl. Clin Trials. 2024 Oct 23:17407745241286065. doi: 10.1177/17407745241286065. Online ahead of print. Clin Trials. 2024. PMID: 39440720 Free article.
Mobility Gaps of Hydrogenated Amorphous Silicon Related to Hydrogen Concentration and Its Influence on Electrical Performance.
Peverini F, Aziz S, Bashiri A, Bizzarri M, Boscardin M, Calcagnile L, Calcatelli C, Calvo D, Caponi S, Caprai M, Caputo D, Caricato AP, Catalano R, Cirro R, Cirrone GAP, Crivellari M, Croci T, Cuttone G, de Cesare G, De Remigis P, Dunand S, Fabi M, Frontini L, Fanò L, Gianfelici B, Grimani C, Hammad O, Ionica M, Kanxheri K, Large M, Lenta F, Liberali V, Lovecchio N, Martino M, Maruccio G, Mazza G, Menichelli M, Monteduro AG, Moscatelli F, Morozzi A, Nascetti A, Pallotta S, Papi A, Passeri D, Petasecca M, Petringa G, Pis I, Placidi P, Quarta G, Rizzato S, Rossi A, Rossi G, Sabbatini F, Scorzoni A, Servoli L, Stabile A, Tacchi S, Talamonti C, Thomet J, Tosti L, Verzellesi G, Villani M, Wheadon RJ, Wyrsch N, Zema N, Pedio M. Peverini F, et al. Among authors: mazza g. Nanomaterials (Basel). 2024 Sep 25;14(19):1551. doi: 10.3390/nano14191551. Nanomaterials (Basel). 2024. PMID: 39404277 Free PMC article.
476 results